These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30550505)

  • 1. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Wang J; Cao B
    Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use.
    Chan HP; Lim TK
    Curr Opin Pulm Med; 2019 Mar; 25(2):150-157. PubMed ID: 30418243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
    Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
    Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
    Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.
    Li Z; Yuan X; Yu L; Wang B; Gao F; Ma J
    Medicine (Baltimore); 2019 Aug; 98(32):e16775. PubMed ID: 31393400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
    Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin-guided antibiotic therapy in AECOPD patients: Overview of systematic reviews.
    Di J; Li X; Xie Y; Yang S; Yu X
    Clin Respir J; 2021 Jun; 15(6):579-594. PubMed ID: 33683808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.
    Huang L; Wang J; Gu X; Sheng W; Wang Y; Cao B
    BMJ Open; 2021 Aug; 11(8):e049515. PubMed ID: 34353802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
    Pandey S; Garg R; Kant S; Verma A; Gaur P
    Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
    Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
    Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
    Tokman S; Schuetz P; Bent S
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Qian W; Huang GZ
    Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
    Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K
    Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.